Cognigenics
Developer of mental healthcare drugs and therapies intended to transform mental health in the genetic age. The company specializes in cognitive neuro-engineering for the genetic engineering of desirab...
Valuation
$0
Share Price
N/A
Total Raised
$1.6M
Last Round
N/A